Trials / Completed
CompletedNCT05656274
A Study of the Safety,Tolerability,and Pharmacokinetics of Multiple-Ascending Dose JS1-1-01 in Healty Subjects.
A Phase 1b，Randomized, Investigator/Participant-Blind, Placebo-Controlled, Multiple-Ascending Dose Trial to Evaluate the Safety, Tolerance and Pharmacokinetics of JS1-1-01 in Healthy Subjects
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 48 (actual)
- Sponsor
- Tasly Pharmaceutical Group Co., Ltd · Industry
- Sex
- All
- Age
- 18 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to evaluate the safety，tolerability，and pharmacokinetics of multiple-accending dose of JS1-1-01。
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | JS1-1-01 | Oral tables |
| DRUG | Placebo | Oral tables |
Timeline
- Start date
- 2022-11-29
- Primary completion
- 2023-07-24
- Completion
- 2023-07-24
- First posted
- 2022-12-19
- Last updated
- 2024-11-19
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT05656274. Inclusion in this directory is not an endorsement.